13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001012975-24-000471
Total Value
$168.5M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 639,539 | $73.1M | 43.38% |
| 2 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $23.5M | 13.95% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,120,508 | $19.7M | 11.71% |
| 4 | OCULIS HOLDING AG | OCSAW | 1,595,918 | $19.6M | 11.61% |
| 5 | ZENAS BIOPHARMA INC | ZBIO | 650,695 | $11.0M | 6.54% |
| 6 | BIOAGE LABS INC | BIOA | 527,647 | $11.0M | 6.51% |
| 7 | EXSCIENTIA PLC | 30223G102 | 770,500 | $3.8M | 2.23% |
| 8 | RALLYBIO CORP | RLYB | 2,404,644 | $2.8M | 1.67% |
| 9 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $1.9M | 1.13% |
| 10 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $1.2M | 0.73% |
| 11 | IO BIOTECH INC | IOBT | 864,197 | $907,407 | 0.54% |